Scott Ravis, MD
Dermatology · Kansas City, MONPI 1902845720
Payments from drug & device makers
Across 234 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$987
- Johnson & Johnson$748
- Novartis$609
- Sun Pharmaceutical Industries Inc.$352
- E.r. Squibb & Sons, L.L.C.$308
- UCB, Inc.$275
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,90291%
- Education$4869%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $987 |
| Johnson & Johnson(2 entities) | 24 | $748 |
| Novartis | 21 | $609 |
| Sun Pharmaceutical Industries Inc. | 11 | $352 |
| E.r. Squibb & Sons, L.L.C. | 21 | $308 |
| UCB, Inc. | 17 | $275 |
| Lilly USA, LLC | 17 | $261 |
| Kerecis Limited | 3 | $233 |
| Amgen | 11 | $210 |
| Galderma Laboratories, L.p. | 3 | $163 |
| Regeneron Healthcare Solutions, Inc. | 6 | $136 |
| Dermavant Sciences, Inc. | 9 | $133 |
| Organogenesis Inc. | 3 | $133 |
| Stemline Therapeutics Inc. | 1 | $125 |
| LEO Pharma Inc. | 6 | $111 |
| Convatec Inc. | 3 | $92 |
| Incyte Corporation | 4 | $89 |
| Pfizer | 5 | $86 |
| Biowound Solutions, Inc. | 2 | $65 |
| Mayne Pharma Commercial LLC | 4 | $49 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Boehringer Ingelheim | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Organon | 2 | $19 |
| Revance Therapeutics, Inc. | 1 | $17 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Biofrontera Inc. | 2 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$567
- Kerecis Omega3 SurgiClose$142
- Rhapsido$132
- ELZONRIS$125
- Skyrizi$119
How this compares
$5,388 in reported general payments places this provider in the 60th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $87,664 |
| Dupixent PenDupilumab | 15 | $60,240 |
| Ketoconazole | 150 | $4,565 |
| Clobetasol Propionate | 85 | $3,356 |
| Tacrolimus | 17 | $3,022 |
| Triamcinolone Acetonide | 172 | $2,854 |
| Fluorouracil | 18 | $1,228 |
| Doxycycline Hyclate | 59 | $1,083 |
| Metronidazole | 14 | $581 |
| Cephalexin | 110 | $505 |
| Betamethasone Dipropionate | 11 | $493 |
| Clindamycin Phosphate | 17 | $390 |
| ValacyclovirValacyclovir Hcl | 15 | $333 |
| Hydrocortisone | 42 | $286 |
| Mupirocin | 27 | $141 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Kansas City
- John RuppKansas City$24K
- Joseph SchneiderKansas City$13K
- Kimberly SchoofsKansas City$13K
- Wenfei XieKansas City$11K
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.